ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
1
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,040
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis
Author(s):
Theodora Simopoulou
,
Sotirios G. Tsiogkas
,
Efterpi Zafiriou
,
Dimitrios P. Bogdanos
Publication date
Created:
March 2023
Publication date
(Print):
March 2023
Journal:
Drugs of Today
Publisher:
Clarivate Analytics (US) LLC
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ScienceOpen Research
Author and article information
Journal
Title:
Drugs of Today
Publisher:
Clarivate Analytics (US) LLC
ISSN (Print):
16993993
ISSN (Print):
16994019
Publication date Created:
March 2023
Publication date (Print):
March 2023
Volume
: 59
Issue
: 3
Pages
: 135-167
Article
DOI:
10.1358/dot.2023.59.3.3419557
PubMed ID:
36847624
SO-VID:
b7bcc1af-12c2-4ae4-ba74-22ac6dbaf833
Copyright ©
© 2023
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,040
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3
Authors:
RB Warren
,
JB Hansen
,
K. REICH
Brodalumab
Authors:
C. Girard
Reply to: “Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials”
Authors:
Mark G. Lebwohl
See all similar
Cited by
1
Regulation of the Immune Cell Repertoire in Psoriasis Patients Upon Blockade of IL-17A or TNFα
Authors:
Julia Tittes
,
Jennifer Brell
,
Pia Fritz
…
See all cited by
Version 1
- Current
Version 1